CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
December 2014—Horizon Discovery Group announced it has agreed to acquire Sage Labs for up to $16 million in cash and up to $32 million through the issue of new ordinary shares. The acquisition of Sage, a provider of next-generation research models, builds on the acquisition of CombinatoRx in July.
The acquisition provides Horizon with an expanded range of genetically engineered preclinical models, important tools for the discovery and development of medicines targeted to the unique genetic drivers of diseases like cancer.
Sage, a former business within Sigma-Aldrich, was known as Sigma Advanced Genetic Engineering and became Sage Labs when it was purchased by management and Telegraph Hill Partners in 2013.
The acquired business will be known as Sage Labs Inc., a wholly owned subsidiary of Horizon Discovery Group plc.
Horizon Discovery Group, +44 (0)1223 655 580